Clinical oncology最新文献

筛选
英文 中文
Strengthening Oncology Data Systems for Equitable Care in Asia-Pacific: Current Practices and Future Directions 加强肿瘤学数据系统在亚太地区的公平护理:目前的做法和未来的方向。
IF 3 3区 医学
Clinical oncology Pub Date : 2026-03-01 Epub Date: 2026-01-21 DOI: 10.1016/j.clon.2026.104051
V. Batumalai , M. Zhou , M. Chilkuri , S. Costello , D. Fraser , S. Ghosh-Laskar , Handoko , A. Liao , A. Teyateeti , G. Xiong , M.L. Yap
{"title":"Strengthening Oncology Data Systems for Equitable Care in Asia-Pacific: Current Practices and Future Directions","authors":"V. Batumalai ,&nbsp;M. Zhou ,&nbsp;M. Chilkuri ,&nbsp;S. Costello ,&nbsp;D. Fraser ,&nbsp;S. Ghosh-Laskar ,&nbsp;Handoko ,&nbsp;A. Liao ,&nbsp;A. Teyateeti ,&nbsp;G. Xiong ,&nbsp;M.L. Yap","doi":"10.1016/j.clon.2026.104051","DOIUrl":"10.1016/j.clon.2026.104051","url":null,"abstract":"<div><h3>Aims</h3><div>Effective oncology data management through oncology information systems (OIS) is essential for high-quality cancer care, yet adoption across the Asia-Pacific (APAC) region varies widely. This study benchmarked OIS utilisation, data capture, and integration across APAC to identify gaps and inform targeted improvements.</div></div><div><h3>Materials and methods</h3><div>A regional survey was distributed to radiotherapy professionals in 19 APAC countries. The questionnaire assessed OIS utilisation, data capture, IT support, training, and system integration. Responses were analysed descriptively and stratified by World Bank income group: low-middle-income countries (L-MIC), upper-middle-income countries (U-MIC), and high-income countries (HIC).</div></div><div><h3>Results</h3><div>A total of 149 responses were analysed. OIS functionality was limited in L-MICs and U-MICs, with only 34% and 59% of centres, respectively, using OIS beyond basic record-and-verify functions. Basic demographic data such as date of birth (83% L-MIC, 90% U-MIC) and sex at birth (98% L-MIC, 91% U-MIC) were consistently captured, but equity-related data were poorly documented (ethnicity 48% U-MIC, 59% HIC; disadvantaged group status rarely recorded in 78% of L-MICs). Radiotherapy data including treatment site (84% to 98%), intent (77% to 90%), and modality (86% to 95%) were consistently documented. However, the location of data capture varied: radiotherapy data were more frequently entered into OIS structured fields (35% L-MIC/U-MIC, 50% HIC), while demographic and diagnosis data showed lower structured capture in OIS (18% to 24% in L-MICs). Reliance on paper records remained widespread in L-MICs and U-MICs.</div></div><div><h3>Conclusion</h3><div>Marked disparities in OIS utilisation and data quality exist across APAC. Regional strategies should prioritise comprehensive training and standardised datasets to improve cancer care quality and equity.</div></div>","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"51 ","pages":"Article 104051"},"PeriodicalIF":3.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146141303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RCR Meetings 软的会议
IF 3 3区 医学
Clinical oncology Pub Date : 2026-03-01 Epub Date: 2026-03-14 DOI: 10.1016/S0936-6555(26)00052-X
{"title":"RCR Meetings","authors":"","doi":"10.1016/S0936-6555(26)00052-X","DOIUrl":"10.1016/S0936-6555(26)00052-X","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"51 ","pages":"Article 104081"},"PeriodicalIF":3.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147448684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can we predict significant toxicity in older patients receiving curative chemotherapy for early stage breast cancer? 我们能否预测早期乳腺癌老年患者接受治疗性化疗的显著毒性?
IF 3 3区 医学
Clinical oncology Pub Date : 2026-03-01 Epub Date: 2026-03-14 DOI: 10.1016/j.clon.2025.104019
Niall Moon, Philippa Smith, Eilidh White, Alastair Thomson
{"title":"Can we predict significant toxicity in older patients receiving curative chemotherapy for early stage breast cancer?","authors":"Niall Moon,&nbsp;Philippa Smith,&nbsp;Eilidh White,&nbsp;Alastair Thomson","doi":"10.1016/j.clon.2025.104019","DOIUrl":"10.1016/j.clon.2025.104019","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"51 ","pages":"Article 104019"},"PeriodicalIF":3.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147448792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
‘Letter to Editor: Impact of Treatment Decisions on Survival Outcomes in Elderly Patients With Non–small Cell Lung Cancer: A Retrospective Real-World Study’ 致编辑:治疗决定对老年非小细胞肺癌患者生存结果的影响:一项回顾性现实世界研究
IF 3 3区 医学
Clinical oncology Pub Date : 2026-03-01 Epub Date: 2026-01-07 DOI: 10.1016/j.clon.2026.104030
A. Irfan
{"title":"‘Letter to Editor: Impact of Treatment Decisions on Survival Outcomes in Elderly Patients With Non–small Cell Lung Cancer: A Retrospective Real-World Study’","authors":"A. Irfan","doi":"10.1016/j.clon.2026.104030","DOIUrl":"10.1016/j.clon.2026.104030","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"51 ","pages":"Article 104030"},"PeriodicalIF":3.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146075380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world experience of the KEYNOTE-522 Regimen in Early Triple-Negative Breast Cancer at University Hospitals Birmingham KEYNOTE-522方案在伯明翰大学医院治疗早期三阴性乳腺癌的实际经验
IF 3 3区 医学
Clinical oncology Pub Date : 2026-03-01 Epub Date: 2026-03-14 DOI: 10.1016/j.clon.2025.104021
Zohaib Sajid , Kabo Mohamed , Mohammad Al-Essa , Sundus Yahya , Maaz Sadiq , Katy Herring , Lynn Do
{"title":"Real-world experience of the KEYNOTE-522 Regimen in Early Triple-Negative Breast Cancer at University Hospitals Birmingham","authors":"Zohaib Sajid ,&nbsp;Kabo Mohamed ,&nbsp;Mohammad Al-Essa ,&nbsp;Sundus Yahya ,&nbsp;Maaz Sadiq ,&nbsp;Katy Herring ,&nbsp;Lynn Do","doi":"10.1016/j.clon.2025.104021","DOIUrl":"10.1016/j.clon.2025.104021","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"51 ","pages":"Article 104021"},"PeriodicalIF":3.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147448731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real world safety and toxicity profile of Pembrolizumab in Neoadjuvant setting in comparison to KEYNOTE-522 与KEYNOTE-522相比,Pembrolizumab在新辅助治疗中的安全性和毒性
IF 3 3区 医学
Clinical oncology Pub Date : 2026-03-01 Epub Date: 2026-03-14 DOI: 10.1016/j.clon.2025.104025
Qurrat-ul-ain Tahir, Henry Brice, Anita Nagetey
{"title":"Real world safety and toxicity profile of Pembrolizumab in Neoadjuvant setting in comparison to KEYNOTE-522","authors":"Qurrat-ul-ain Tahir,&nbsp;Henry Brice,&nbsp;Anita Nagetey","doi":"10.1016/j.clon.2025.104025","DOIUrl":"10.1016/j.clon.2025.104025","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"51 ","pages":"Article 104025"},"PeriodicalIF":3.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147448901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing if a Random Cortisol is sufficient to guide surgical safety in TNBC treated with Neoadjuvant Immunotherapy: The Oxford experience 评估随机皮质醇是否足以指导新辅助免疫治疗TNBC的手术安全性:牛津经验
IF 3 3区 医学
Clinical oncology Pub Date : 2026-03-01 Epub Date: 2026-03-14 DOI: 10.1016/j.clon.2025.104023
Pavetha Seeva, Nicky Levitt, Helen Turner, Ramnik Buttar
{"title":"Assessing if a Random Cortisol is sufficient to guide surgical safety in TNBC treated with Neoadjuvant Immunotherapy: The Oxford experience","authors":"Pavetha Seeva,&nbsp;Nicky Levitt,&nbsp;Helen Turner,&nbsp;Ramnik Buttar","doi":"10.1016/j.clon.2025.104023","DOIUrl":"10.1016/j.clon.2025.104023","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"51 ","pages":"Article 104023"},"PeriodicalIF":3.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147448682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authors’ Response to Re-evaluating the 30 Gy Dose for Chest Wall-Abutting Tumours in Single-Fraction Stereotactic Ablative Radiotherapy: Evidence From a Population-Based Study 作者对在单次立体定向消融放疗中重新评估30 Gy胸壁邻近肿瘤剂量的反应:来自人群研究的证据。
IF 3 3区 医学
Clinical oncology Pub Date : 2026-03-01 Epub Date: 2026-01-07 DOI: 10.1016/j.clon.2026.104031
J.M. Callueng , M. Liu , B. Mou
{"title":"Authors’ Response to Re-evaluating the 30 Gy Dose for Chest Wall-Abutting Tumours in Single-Fraction Stereotactic Ablative Radiotherapy: Evidence From a Population-Based Study","authors":"J.M. Callueng ,&nbsp;M. Liu ,&nbsp;B. Mou","doi":"10.1016/j.clon.2026.104031","DOIUrl":"10.1016/j.clon.2026.104031","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"51 ","pages":"Article 104031"},"PeriodicalIF":3.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146046279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Readiness for adjuvant ribociclib – results of a local audit and national survey 对辅助核糖环苷的准备-地方审计和全国调查的结果
IF 3 3区 医学
Clinical oncology Pub Date : 2026-03-01 Epub Date: 2026-03-14 DOI: 10.1016/j.clon.2025.104015
Eliza Gimson, Juliet Richman, Neha Chopra, Amna Sheri, Jackie Newby, Judy King
{"title":"Readiness for adjuvant ribociclib – results of a local audit and national survey","authors":"Eliza Gimson,&nbsp;Juliet Richman,&nbsp;Neha Chopra,&nbsp;Amna Sheri,&nbsp;Jackie Newby,&nbsp;Judy King","doi":"10.1016/j.clon.2025.104015","DOIUrl":"10.1016/j.clon.2025.104015","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"51 ","pages":"Article 104015"},"PeriodicalIF":3.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147448866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neoadjuvant chemotherapy plus pembrolizumab vs chemotherapy alone for patients with early and advanced triple-negative breast cancer (TNBC): Outcomes from Berkshire Cancer Centre 早期和晚期三阴性乳腺癌(TNBC)患者的新辅助化疗联合派姆单抗与单独化疗:来自伯克希尔癌症中心的结果
IF 3 3区 医学
Clinical oncology Pub Date : 2026-03-01 Epub Date: 2026-03-14 DOI: 10.1016/j.clon.2025.104026
Ismini Tsagkaraki, Anil Babar, Madhumita Bhattacharyya
{"title":"Neoadjuvant chemotherapy plus pembrolizumab vs chemotherapy alone for patients with early and advanced triple-negative breast cancer (TNBC): Outcomes from Berkshire Cancer Centre","authors":"Ismini Tsagkaraki,&nbsp;Anil Babar,&nbsp;Madhumita Bhattacharyya","doi":"10.1016/j.clon.2025.104026","DOIUrl":"10.1016/j.clon.2025.104026","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"51 ","pages":"Article 104026"},"PeriodicalIF":3.0,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147448899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书